7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31 2009-12-31 2009-09-30 2009-06-30 2009-03-31 2008-12-31 2008-09-30 2008-06-30 2008-03-31 2007-12-31 2007-09-30 2007-06-30 2007-03-31 2006-12-31 2006-09-30 2006-06-30 2006-03-31 2005-12-31 2005-09-30 2005-06-30 2005-03-31 2004-12-31 2004-09-30 2003-12-31 2003-09-30 2003-06-30 2003-03-31 2002-12-31 2002-09-30 2002-06-30 2002-03-31 
      
    		                                                                                             
      cash flows from operating activities:
    		                                                                                             
      net income
    		29,288,000 -116,202,000 -1,092,000 -187,533,000 6,989,000 16,237,000 17,328,000 12,489,000 53,174,000 60,906,000 84,110,000 81,797,000 92,445,000 123,800,000 146,008,000 116,217,000 74,023,000 66,770,000 70,378,000 9,308,000 26,067,000 22,325,000 12,965,000 27,482,000 23,515,000 28,869,000 34,122,000 35,613,000 27,918,000 35,529,000 42,681,000 41,167,000 28,128,000 31,255,000 32,008,000 26,351,000 27,296,000 26,322,000 25,869,000 20,165,000 33,647,000 15,870,000 12,209,000 9,895,000 8,499,000 7,193,000 7,630,000 8,356,000 8,615,000 8,399,000 7,563,000 7,083,000 5,858,000 -81,000 4,276,000 -2,435,000 -26,899,000 813,000 2,256,000 -1,618,000 -51,290,000 137,000 780,000 -2,722,000 -1,995,000 4,374,000 -121,834,000 7,624,000 7,850,000 9,367,000 9,516,000 9,004,000 10,088,000 9,246,000 8,194,000 10,047,000 9,472,000 7,271,000 8,301,000 6,977,000 6,848,000 4,416,000 3,993,000 4,534,000 3,930,000 4,917,000 9,286,000 11,190,000 12,399,000 14,406,000 14,292,000 12,481,000 11,177,000 
      adjustments to reconcile net income to net cash from operating activities:
    		                                                                                             
      depreciation and amortization
    		39,628,000 39,885,000 39,857,000 41,474,000 43,050,000 44,738,000 44,517,000 43,132,000 40,727,000 38,234,000 38,834,000 38,024,000 34,330,000 33,247,000 31,510,000 27,826,000 26,790,000 25,356,000 23,725,000 24,110,000 27,417,000 22,426,000 20,234,000 17,007,000 17,085,000 12,718,000 11,710,000 11,449,000 11,296,000 10,606,000 7,886,000 8,520,000 8,132,000 7,959,000 7,668,000 7,732,000 7,789,000 7,334,000 6,765,000 5,322,000 5,304,000 5,232,000 5,095,000 4,077,000 4,086,000 4,010,000 3,820,000 3,698,000 3,317,000 3,240,000 3,290,000 3,469,000 3,435,000 3,552,000 3,695,000 3,878,000 3,954,000 4,119,000 4,465,000 4,836,000 3,787,000 3,163,000 3,298,000 3,408,000 3,495,000 3,442,000 3,467,000 3,581,000 3,770,000 3,738,000 3,350,000 3,209,000 2,979,000 2,857,000 2,629,000 2,697,000 2,638,000 2,524,000 2,466,000 2,162,000 1,481,000 1,457,000 1,079,000 1,411,000 1,425,000 1,351,000 1,203,000 1,150,000 1,115,000 1,302,000 935,000   
      non-cash interest expense and other
    		608,000 609,000 608,000 10,309,000 534,000 533,000 534,000 7,234,000 549,000 533,000 505,000 3,903,000 474,000 474,000 479,000 474,000 -4,290,000 510,000 -761,000 622,000 910,000 906,000 1,911,000 168,000 682,000 591,000 543,000 -5,432,000 -686,000 677,000 600,000 513,000 597,000 542,000 579,000 1,236,000 455,000 149,000 576,000 489,000 454,000 534,000 457,000 288,000 428,000 381,000 295,000                                               
      increase in allowance for credit losses and sales credits
    		-2,993,000 3,564,000 2,182,000 -2,260,000 -2,371,000 7,539,000 388,000 -8,055,000 2,536,000 3,985,000 25,447,000 35,800,000 8,396,000 10,371,000 3,432,000 4,160,000 2,629,000 -4,917,000 4,391,000 -1,045,000 838,000 2,007,000 4,735,000                                                                       
      benefit from deferred income taxes
    		16,879,000 -27,938,000 -5,824,000 -45,159,000 -3,307,000 5,060,000 -7,661,000 -21,428,000 24,275,000 -9,141,000 -6,639,000 -19,251,000 -8,785,000 -15,105,000 18,526,000 -11,959,000 -2,938,000 -3,318,000 1,928,000 -3,705,000 -8,096,000 -10,560,000 733,000 4,613,000 6,628,000 -1,292,000 -9,036,000 1,717,000 4,789,000 -2,060,000 -5,113,000 15,119,000 -488,000 -4,124,000 -4,900,000 -6,215,000 -2,790,000 782,000 -1,201,000 -5,006,000 11,454,000 870,000 5,359,000 10,011,000 2,842,000 -2,959,000 1,885,000 1,080,000 1,089,000 -161,000 1,023,000 2,504,000 3,120,000 -1,733,000 3,060,000 -1,100,000 -1,230,000 -803,000 1,338,000 -1,265,000 -8,678,000 21,000 -789,000 2,494,000 -2,612,000 -2,029,000 -49,574,000 -1,165,000 -823,000   -1,480,000 3,437,000 -1,709,000 892,000 5,415,000 5,254,000 1,913,000 5,495,000 15,504,000 1,549,000 1,346,000 618,000 -1,050,000 3,408,000     7,243,000    
      share-based compensation
    		6,713,000 8,827,000 9,381,000 3,666,000 5,555,000 6,357,000 7,739,000 2,578,000 306,000 4,818,000 10,318,000 5,396,000 4,898,000 8,513,000 11,259,000 7,322,000 2,589,000 6,019,000 9,287,000 5,419,000 3,772,000 6,347,000 4,927,000 4,528,000 2,825,000 3,702,000 5,186,000 2,861,000 1,809,000 3,281,000 2,864,000 2,517,000 2,477,000 2,562,000 2,681,000 2,604,000 2,704,000 2,710,000 3,381,000 3,733,000 2,021,000 2,153,000 2,377,000 1,796,000 1,791,000 1,751,000 1,819,000 1,458,000 1,487,000                                             
      loss on disposal or impairment of long-lived assets
    		-2,000 18,269,000 27,000 23,000 23,000 9,000 10,000 6,260,000 -140,000 84,000 1,849,000                                                                                   
      gain on sale of disposal group
    		                                                                                             
      net gain on investments in available-for-sale securities
    		-40,000           97,000 116,000                                                                                 
      goodwill impairment loss
    		0                                                                                             
      net gain on deferred compensation balances
    		1,158,000 561,000 502,000 -36,000 226,000 -1,034,000 -381,000 765,000 277,000 -618,000 41,000 798,000 -1,285,000 531,000 -570,000    370,000    -240,000                                                                       
      non-cash lease expense
    		-365,000 13,000 28,000 -341,000 -313,000 209,000 -799,000 473,000 1,386,000 -12,000 -228,000 679,000 1,276,000 662,000 2,880,000 4,063,000 537,000 -365,000 -429,000 -833,000 64,000 359,000 -179,000 6,000 105,000 -14,000 -92,000                                                                   
      changes in assets and liabilities, net of effects from acquisitions:
    		                                                                                             
      accounts receivable
    		-339,000 26,894,000 13,766,000 13,269,000 60,222,000 61,369,000 41,367,000 -7,539,000 11,666,000 103,282,000 -37,376,000 13,389,000 48,067,000 190,509,000 -194,044,000 -223,191,000 -104,431,000 99,360,000 -191,271,000 -22,489,000 12,991,000 7,946,000 -5,786,000 3,132,000 12,719,000 13,927,000 -1,500,000 -2,196,000 -13,087,000 4,676,000 9,154,000 -8,227,000 -10,271,000 -2,147,000 1,787,000 -16,106,000 -1,160,000 -26,215,000 -15,219,000 -28,921,000 -19,393,000 -10,896,000 -16,443,000 -22,442,000 -13,335,000 -2,375,000 -3,806,000 -3,542,000 3,834,000 6,406,000 -15,342,000 -2,113,000 -7,195,000 3,633,000 3,033,000 -4,163,000 -5,919,000 -2,265,000 -11,254,000 -1,818,000 -9,152,000 -23,000 -26,000 2,578,000 18,132,000 33,834,000 34,186,000 12,073,000 6,169,000 -277,000 -7,559,000 8,387,000 -515,000 -6,541,000 4,203,000 -12,993,000 -24,233,000 -5,038,000 1,665,000 -1,042,000 137,000 2,023,000 -1,592,000 -1,088,000 2,565,000 -3,930,000 216,000 17,350,000 3,743,000 -5,234,000 1,309,000   
      accounts receivable, subcontractor
    		7,492,000 6,205,000 5,174,000 -1,915,000 12,730,000 16,220,000 20,187,000 58,273,000 -7,745,000 108,424,000 -7,929,000 -14,772,000 -6,247,000 42,604,000 -50,592,000 -98,093,000 -11,217,000 7,958,000 -64,382,000 -17,685,000 2,169,000 17,469,000 -3,224,000 -9,961,000 -12,694,000 5,549,000 -5,465,000 -5,252,000 -10,234,000 4,370,000 1,985,000 -3,812,000 -569,000 12,207,000 395,000 -7,139,000 4,233,000 3,532,000 916,000 -1,287,000 -12,612,000 -2,718,000 -5,748,000 -6,874,000 943,000 -3,832,000 -409,000 598,000 -3,141,000 3,604,000 -865,000 1,219,000 2,310,000 1,344,000 -843,000 -5,056,000 -1,739,000 122,000 1,258,000 -1,304,000 3,982,000                                 
      income taxes receivable
    		-5,633,000 -4,477,000 5,568,000 -409,000 56,000 -9,009,000 5,350,000 -5,082,000 0 0 8,875,000 -7,449,000 -404,000   1,119,000 681,000 -1,800,000 6,591,000 -6,569,000 0 173,000 5,984,000 -1,063,000 -1,728,000 -2,472,000 799,000 2,102,000 -989,000 4,105,000 9,881,000 -13,683,000 -1,029,000 -1,186,000 361,000 309,000 712,000 -558,000 6,006,000 6,859,000 -4,195,000 32,000 5,171,000         1,986,000 782,000 501,000 -234,000 -1,162,000 -196,000 1,257,000 489,000 -338,000 -756,000 69,000 1,165,000   3,023,000 -1,008,000            -2,677,000               
      prepaid expenses
    		523,000 5,936,000 -2,134,000 -5,438,000 2,600,000 4,254,000 -3,392,000 -1,886,000 -399,000 8,731,000 -7,988,000 -1,689,000 10,412,000 11,710,000 33,373,000 -53,093,000 -1,509,000 2,004,000 -6,190,000 2,019,000 -101,000 4,403,000 -7,663,000 -344,000 2,641,000 3,864,000 -5,387,000 2,131,000 4,346,000 363,000 -2,375,000 -673,000 1,321,000 2,345,000 -5,309,000 -260,000 1,818,000 456,000 -2,469,000 -702,000                                                      
      other current assets
    		10,765,000 5,419,000 -10,256,000 -8,693,000 1,917,000 -2,526,000 772,000 404,000 1,973,000 1,935,000 -115,000 5,376,000 -2,939,000 3,158,000 12,180,000 -25,410,000 103,000 -918,000 4,226,000 -655,000 2,393,000 -2,879,000 3,463,000 1,515,000 749,000 2,366,000 -1,783,000 -1,705,000 1,059,000 -3,438,000 2,825,000 -11,089,000 4,593,000 2,617,000 2,945,000 -3,829,000 -2,719,000 -5,913,000 -1,477,000 702,000                                                      
      other assets
    		824,000 2,308,000 1,337,000 -278,000 1,985,000 -1,706,000 86,000 -2,074,000 -1,997,000 673,000 221,000 818,000 -1,610,000 1,344,000 -342,000 2,482,000 -182,000 1,293,000 -331,000 -158,000 234,000 735,000 2,409,000 -3,961,000 -27,000 -2,561,000 -6,202,000 6,258,000 -1,575,000 645,000 -89,000 -202,000 559,000 -2,624,000 -3,139,000 733,000 -253,000 -1,571,000 -2,471,000 -1,331,000 -761,000 -543,000 -2,150,000 -80,000 -134,000 552,000 -606,000 -177,000                                              
      accounts payable and accrued expenses
    		-4,528,000 -16,212,000 9,456,000 -23,094,000 -71,988,000 -26,802,000 -33,006,000 -60,754,000 37,099,000 -150,305,000 -9,557,000 16,927,000 2,394,000 -41,527,000 70,988,000 143,935,000 20,360,000 -11,455,000 103,278,000 11,046,000 8,551,000 -29,871,000 15,836,000 16,202,000 15,194,000 -32,420,000 2,949,000 9,843,000 16,265,000 -1,138,000 -7,816,000 12,580,000 -1,927,000 -16,916,000 -1,599,000 18,496,000 -13,356,000 22,794,000 -10,229,000 3,803,000 11,746,000 10,441,000 3,621,000 10,281,000 1,881,000 26,000 -6,063,000 2,765,000 1,245,000 -3,775,000 4,102,000 9,055,000 -7,147,000 -683,000 1,608,000 2,657,000 4,250,000 -3,752,000 505,000 5,901,000 -7,202,000 3,801,000 6,436,000 -872,000 -1,908,000 -3,830,000 247,000 -3,541,000 -860,000 361,000 5,981,000 301,000 298,000 -558,000 1,681,000 -2,309,000 -217,000 2,301,000 1,406,000 -649,000 -1,719,000 1,400,000 -236,000 -1,309,000 3,641,000 3,187,000 -1,609,000 -818,000 -544,000 -676,000 1,487,000   
      accrued compensation and benefits
    		8,512,000 -5,571,000 -13,995,000 4,772,000 4,912,000 -14,629,000 -6,365,000 -1,845,000 6,547,000 -13,799,000 -71,038,000 -13,443,000 -70,412,000 -23,137,000 96,486,000 32,569,000 31,565,000 116,000 64,985,000 18,226,000 8,817,000 844,000 -2,031,000 12,971,000 8,013,000 11,444,000 330,000 -762,000 5,546,000 9,475,000 -4,007,000 9,439,000 4,701,000 7,641,000 -8,351,000 8,381,000 -2,887,000 3,873,000 9,775,000 -4,819,000 11,367,000 4,344,000 996,000 2,890,000 8,529,000 -912,000 1,008,000 465,000 7,349,000 -2,522,000 -50,000 197,000 6,223,000 -694,000 68,000 595,000 -2,412,000 152,000 7,700,000 -4,783,000 1,266,000 -773,000 4,124,000 -5,377,000 -2,510,000 -4,787,000 -8,143,000 -5,105,000 1,121,000 1,528,000 3,214,000 -1,435,000 1,765,000 1,329,000 -1,222,000 -582,000 7,471,000 3,513,000 -25,000 -2,073,000 -6,445,000 -2,890,000 11,968,000 -7,292,000 3,633,000 -3,653,000 2,009,000 -3,407,000 2,680,000 -1,133,000 4,616,000   
      other liabilities
    		-42,133,000 16,074,000 36,006,000 54,732,000 2,677,000 -7,266,000 -5,712,000 -62,751,000 1,616,000 38,984,000 11,903,000 -27,032,000 5,195,000 -123,082,000 18,353,000 148,953,000 -20,503,000 -14,804,000 9,039,000 12,048,000 6,828,000 29,658,000 -6,894,000 1,183,000 -1,421,000 -15,482,000 9,630,000 1,443,000 -3,835,000 -5,090,000 -1,498,000 -3,330,000 -5,637,000 -16,300,000 16,825,000 2,411,000 4,117,000 -12,460,000 14,079,000 2,262,000 -13,163,000 4,416,000 4,382,000 -9,113,000 3,478,000 798,000 349,000 398,000 1,500,000 2,665,000 -779,000 -3,044,000 1,771,000 -349,000 -2,097,000    -2,369,000 -451,000 -2,090,000 -214,000 -1,685,000 -2,154,000 2,423,000 -2,390,000 -1,406,000 1,110,000 1,789,000 58,000 1,482,000 3,569,000 1,734,000 959,000 206,000 -2,441,000 1,580,000 616,000 588,000 2,040,000 404,000 484,000 333,000 2,489,000 -1,682,000 6,000 458,000 -97,000 9,000  0   
      deferred revenue
    		-4,511,000 4,902,000 2,076,000 -2,735,000 1,186,000 -151,000 360,000 -1,398,000 271,000 -1,471,000 2,040,000 -3,289,000 -915,000 232,000 -126,000 -1,956,000 2,694,000 -212,000 3,794,000 -1,087,000 40,000 -820,000 748,000 232,000 -13,000 -607,000 -1,418,000 -743,000 -511,000 1,625,000 -52,000 -1,226,000 -38,000 800,000 -84,000 476,000 2,299,000 -2,329,000 286,000 173,000 -674,000 2,346,000 -532,000                                                   
      net cash from operating activities
    		22,666,000 78,548,000 92,671,000 72,814,000 66,703,000 99,515,000 81,386,000 -41,130,000 172,194,000 197,667,000 43,434,000 115,328,000 113,728,000 224,462,000 200,215,000 77,985,000 16,746,000 171,494,000 39,131,000 39,845,000 88,710,000 76,906,000 51,365,000 78,657,000 80,914,000 29,077,000 36,214,000 58,947,000 42,108,000 66,203,000 59,735,000 18,880,000 25,594,000 18,474,000 52,314,000 47,031,000 29,540,000 20,053,000 35,227,000 676,000 21,950,000 25,000,000 8,687,000 5,039,000 15,489,000 6,159,000 991,000 15,538,000 26,577,000 19,221,000 -2,699,000 18,450,000 11,512,000 20,997,000 9,553,000 6,513,000 4,881,000 2,354,000 5,564,000 4,849,000 21,501,000 -29,976,000 11,715,000 5,582,000 19,205,000 36,388,000 37,557,000 13,802,000 21,136,000 11,883,000 16,873,000 25,326,000 20,817,000 16,251,000 17,242,000 8,590,000 3,799,000 24,124,000 18,025,000 15,894,000 2,028,000 9,234,000 16,934,000 -1,778,000 19,929,000 998,000 17,447,000 25,029,000 21,671,000 9,019,000 31,598,000   
      cash flows from investing activities:
    		                                                                                             
      purchase and development of fixed assets
    		-7,908,000 -9,800,000 -9,975,000 -16,220,000 -19,260,000 -27,266,000 -18,145,000 -29,856,000 -29,895,000 -26,449,000 -17,487,000 -24,602,000 -20,418,000 -17,221,000 -13,590,000 -14,863,000 -15,641,000 -11,462,000 -11,607,000 -10,345,000 -7,630,000 -6,156,000 -13,571,000 -10,442,000 -9,244,000 -8,144,000 -7,388,000 -11,284,000 -7,465,000 -10,754,000 -5,703,000 -9,361,000 -5,427,000 -6,243,000 -5,498,000 -4,251,000 -4,811,000 -6,276,000 -6,618,000 -5,888,000 -6,518,000 -8,234,000 -6,370,000 -4,847,000 -4,411,000 -4,033,000 -5,843,000 -2,600,000 -1,099,000 -3,133,000 -2,215,000 -1,719,000 -1,543,000 -1,209,000 -1,001,000 -1,098,000 -1,099,000 -764,000 -1,687,000 -1,783,000 -1,115,000 -599,000 -671,000 -612,000 -743,000 -1,204,000 -1,230,000 -1,653,000 -1,963,000 -2,527,000 -2,612,000 -2,660,000 -1,859,000 -2,501,000 -2,131,000 -2,997,000 -2,290,000 -2,886,000 -1,541,000 -762,000 -1,104,000 -1,181,000 -771,000           
      purchase of investments
    		-963,000 -12,397,000 -21,722,000         0 -2,493,000 -6,641,000 -4,018,000 -28,282,000 -14,442,000 -7,696,000 -10,299,000 -10,893,000 -14,289,000 -18,650,000 -4,479,000 -9,550,000 -3,478,000 -5,919,000 -7,362,000 -6,639,000 -20,443,000 -4,656,000 -2,086,000 -4,075,000 -3,770,000 -2,447,000 -4,804,000                                                           
      proceeds from sale and maturity of investments
    		2,539,000 0 7,239,000 3,400,000 1,207,000 3,285,000 1,207,000 0 2,907,000 4,980,000 2,007,000 1,835,000 3,464,000 2,200,000 6,885,000                                                                               
      proceeds from sale of disposal group
    		                                                                                             
      payments to fund deferred compensation plan
    		-2,869,000 -1,668,000 -1,588,000 0 -3,951,000 0 -4,461,000 0 -6,992,000 -959,000 -16,951,000 -107,000 -8,827,000 0 -12,584,000 -1,471,000 -4,703,000   0 -980,000 -720,000 -5,471,000 -1,143,000 -6,085,000 -1,696,000 -3,583,000 -2,117,000 -3,076,000 0 -4,724,000 -481,000 -3,232,000 -1,826,000 -4,998,000 -1,246,000 -2,603,000 -207,000 -2,855,000 -754,000 -98,000 -949,000 -1,203,000 0 -775,000 -184,000 -1,215,000                                               
      proceeds from settlements of company-owned life insurance policies
    		2,873,000                                                                                             
      cash received for working capital settlement of prior year acquisition
    		   0 0                                                                                         
      net cash from investing activities
    		58,992,000 -20,591,000 -26,046,000 -14,203,000 -22,004,000 -22,332,000 -21,399,000 -323,731,000 -33,903,000 -22,428,000 -32,431,000 -22,643,000 -32,305,000 -92,523,000 -23,239,000 -28,385,000 -25,408,000 -56,403,000 2,794,000 -9,714,000 -15,196,000 -21,125,000 -492,137,000 -38,218,000 -12,915,000 -204,443,000 -36,248,000 -7,689,000 -32,698,000 -229,337,000 -9,613,000 -10,002,000 -3,823,000 -6,320,000 -13,301,000 -16,091,000 -8,117,000 -58,451,000 -174,703,000 -10,451,000 -10,768,000 -9,516,000 -85,350,000 -17,908,000 -4,511,000 -1,100,000 -4,709,000 -42,100,000 -503,000 -3,142,000 -2,155,000 -1,257,000 -2,103,000 -1,031,000 7,352,000 -1,142,000 -1,107,000 1,955,000 -1,687,000 -2,805,000 -3,835,000 462,000 -668,000 -22,887,000 -3,924,000 -1,204,000 -1,230,000 -1,819,000 -1,963,000 -11,064,000 -33,401,000 -2,656,000 -1,859,000 -7,983,000 -2,131,000 -2,997,000 -2,290,000 -2,886,000 -37,504,000 -111,859,000 -1,105,000 -1,591,000 -771,000 -1,070,000 -1,458,000 -1,955,000 -4,026,000 -4,772,000 -3,260,000 10,086,000 -3,715,000   
      cash flows from financing activities:
    		                                                                                             
      payments on revolving credit facility
    		-100,000,000 -90,000,000 -95,000,000 -115,000,000 -120,000,000 -90,000,000 -50,000,000 -25,000,000 -110,000,000 -150,000,000 -70,000,000     0 0 -55,000,000 -15,000,000 -40,000,000 -80,000,000   -146,000,000 -50,000,000   -30,000,000 -5,000,000       -182,500,000    2,000,000 -10,000,000 -10,000,000 -7,000,000 0   -1,000,000 -15,000,000 0   0 0 0 -3,000,000      0   0 0 -6,500,000 -25,000,000 -5,000,000 0 -18,500,000 -11,500,000                       
      proceeds from revolving credit facility
    		30,000,000 10,000,000 35,000,000 40,000,000 60,000,000 10,000,000 15,000,000 390,000,000 15,000,000 200,000,000 210,000,000     0 0 0 70,000,000 0 20,000,000 0 225,000,000 0 0 71,000,000 30,000,000 0 0       0 0 39,000,000 85,000,000 5,000,000 0 0 84,500,000 18,000,000   1,000,000 25,000,000 0 0 1,000,000  0 0 0 5,300,000 9,600,000 2,700,000 2,300,000         0 12,000,000 29,500,000 25,000,000                       
      payment of financing costs
    		       0 0 0 -3,579,000         -4,610,000 -2,717,000 -282,000 -3,899,000 -4,348,000 -98,000   0 0 0 -2,331,000     -6,113,000 0 0 -448,000     0 0   571,000 0   0 -40,000   0    66,000 -3,695,000   -4,415,000 1,000   0 0       3,000 -21,000   -4,822,000 0   0  -3,644,000 -29,000 0 -955,000 -63,000 -21,000 0 -17,000 
      cash paid for shares withheld for taxes
    		-266,000 -226,000 -1,211,000 -224,000 -469,000 -108,000 -3,973,000 -1,205,000 -2,522,000 -3,287,000 -6,134,000 -1,466,000 -3,835,000 -366,000 -9,431,000 -977,000 -527,000 -470,000 -5,258,000 -2,131,000 -158,000 -287,000 -4,353,000 -431,000 -1,809,000 -1,253,000 -10,280,000 0 -24,000 -482,000 -10,926,000 -302,000 -58,000 -1,701,000 -7,313,000 -227,000 0 -360,000 -5,194,000 -395,000 -195,000 -2,624,000 -8,694,000 -87,000 -118,000 -338,000 -3,905,000 -8,000 -125,000 -1,134,000 -1,403,000                                           
      net cash from financing activities
    		-71,214,000 -80,226,000 -61,211,000 -79,898,000 -60,469,000 -80,108,000 -38,973,000 363,495,000 -105,022,000 -203,287,000 -44,457,000 -176,342,000 -3,835,000 -174,233,000 -237,455,000 -3,665,000 -527,000 -55,470,000 24,767,000 -55,071,000 -62,437,000 -127,132,000 456,126,000 159,000 -52,845,000 187,495,000 1,790,000 -44,263,000 -36,883,000 133,627,000 -14,970,000 -13,369,000 -24,951,000 -26,945,000 -11,928,000 -36,128,000 -26,817,000 36,268,000 152,967,000 4,910,000 -11,302,000 -12,563,000 75,155,000 16,166,000   -2,584,000 10,525,000 -4,856,000 -7,471,000 1,019,000  -21,029,000 -9,402,000 -15,923,000 -6,070,000 -7,087,000 -318,000 -1,825,000 -2,240,000 -20,462,000 -2,211,000 -1,536,000 21,721,000 -16,157,000 -28,420,000 -30,954,000 -8,296,000 -19,627,000 -345,000 5,934,000 -10,316,000 -30,319,000 -984,000 -9,304,000 -4,752,000 -2,817,000 -26,670,000 10,703,000 100,417,000 -1,035,000 -3,299,000 -9,563,000 -2,499,000 -23,076,000 -50,397,000 -841,000 -5,378,000 -29,853,000 -37,861,000 233,000   
      effect of exchange rate changes on cash
    		              -183,000 -325,000 11,000 3,000 -24,000 7,000 -14,000 -58,000 -47,000 59,000 132,000 -89,000 -101,000 58,000 133,000 91,000 -19,000 13,000 -73,000 -42,000 4,000 102,000 40,000 86,000 39,000  54,000 -80,000 68,000 113,000   -9,000  -84,000 -28,000 93,000  -55,000 33,000 -43,000 18,000 32,000 -1,000 -1,000 2,000 27,000 4,000 3,000 16,000 9,000 49,000 -14,000 -176,000 -97,000 47,000 -66,000 -29,000 4,000 22,000 -8,000 70,000 -69,000 0 -14,000 -81,000 13,000 -24,000 10,000      -60,000     
      net increase in cash, cash equivalents and restricted cash
    		10,444,000 -22,269,000 5,414,000  -15,770,000 -2,925,000 21,014,000     -83,657,000 77,588,000 -42,111,000 -60,662,000 45,610,000 -9,178,000 59,624,000 66,668,000 -24,933,000 11,063,000 -71,409,000 15,307,000 40,657,000 15,286,000 12,040,000 1,655,000 7,053,000 -27,340,000 -29,416,000 35,133,000                                                               
      cash, cash equivalents and restricted cash at beginning of period
    		0 0 89,305,000  0 0 108,273,000  0 0 137,872,000  0 0 246,714,000  0 0 83,990,000  0 0 153,962,000  0 0 84,324,000  0 0 98,894,000                                                               
      cash, cash equivalents and restricted cash at end of period
    		10,444,000 -22,269,000 94,719,000  -15,770,000 -2,925,000 129,287,000  33,269,000 -28,048,000 104,418,000  77,588,000 -42,111,000 186,052,000  -9,178,000 59,624,000 150,658,000  11,063,000 -71,409,000 169,269,000  15,286,000 12,040,000 85,979,000  -27,340,000 -29,416,000 134,027,000                                                               
      supplemental disclosures of cash flow information:
    		                                                                                             
      cash paid for amounts included in the measurement of operating lease liabilities
    		2,487,000 2,153,000 2,138,000 2,510,000 2,579,000 2,460,000 2,805,000 2,420,000 1,962,000 2,319,000 2,610,000 2,637,000 2,778,000 3,692,000 4,230,000 4,799,000 25,326,000 4,846,000 4,894,000 4,973,000 4,967,000 5,378,000 4,734,000 4,523,000 4,600,000 4,356,000 4,338,000                                                                   
      cash paid for interest
    		785,000 20,661,000 2,939,000 22,909,000 5,400,000 25,182,000 7,543,000 23,014,000 2,435,000 21,599,000 1,053,000 18,568,000 63,000 18,691,000 196,000 18,784,000 273,000 18,708,000 320,000 8,804,000 1,089,000 10,861,000 1,898,000 8,742,000 3,274,000 10,190,000 1,524,000 9,762,000 1,354,000 9,966,000 201,000 8,541,000 266,000          1,330,000    1,588,000    2,399,000  2,925,000 3,547,000 4,520,000   4,507,000 4,626,000   1,803,000 1,825,000 2,667,000 1,398,000 1,598,000 1,724,000 2,448,000 2,271,000 2,340,000 2,541,000 2,852,000 2,954,000 3,023,000 2,996,000 3,241,000 3,543,000 3,628,000 3,488,000 2,810,000 1,366,000 1,401,000 1,493,000 1,617,000 1,714,000 1,817,000 96,000 0 90,000 64,000 65,000 63,000 62,000 
      cash paid for income taxes
    		-2,899,000 9,085,000 2,139,000 6,477,000 4,095,000 13,271,000 4,309,000 67,423,000 1,097,000 4,332,000 5,404,000 49,050,000 44,097,000 110,836,000 9,824,000 33,516,000 28,802,000 38,495,000 5,566,000 15,531,000 30,668,000 14,000 45,000 5,290,000 5,088,000 23,177,000 4,192,000 9,370,000 6,818,000 11,674,000 2,731,000 7,748,000 20,834,000              223,000    4,876,000  49,000 198,000 116,000  335,000 835,000 336,000  -56,000 165,000 761,000 551,000 3,366,000 684,000 1,008,000 6,057,000 7,370,000 13,098,000 6,422,000   110,000 884,000   708,000 2,194,000 618,000 2,378,000 2,127,000 1,231,000 1,647,000 127,000 3,278,000 2,595,000 9,153,000 2,359,000 8,374,000 589,000 7,575,000 326,000 
      supplemental disclosures of non-cash investing and financing activities:
    		                                                                                             
      purchase of fixed assets recorded in accounts payable and accrued expenses
    		41,000 -4,047,000 5,405,000 -6,391,000 1,552,000 -4,740,000 12,777,000 -6,711,000 3,913,000 4,079,000 6,849,000 456,000 -2,375,000 2,791,000 4,771,000 -1,361,000 1,415,000 -123,000 3,788,000 2,096,000 -218,000 -561,000 1,786,000 159,000 -210,000 -214,000 2,566,000 -2,798,000 2,704,000 -1,060,000 2,860,000 -194,000 917,000                                                             
      right-of-use assets obtained in exchange for operating lease liabilities
    		809,000 0 544,000 74,000 495,000 2,136,000 2,338,000 10,766,000 -420,000                                                                                     
      net income on investments in available-for-sale securities
    		  4,000 3,000 20,000 113,000 64,000  73,000 74,000 81,000                                                                                   
      change in fair value of contingent consideration liabilities
    		       0 0 2,350,000 80,000                                                                                   
      goodwill impairment losses
    		                                                                                             
      proceeds from sale of equity investment
    		       0    0 0 0 68,000 0    224,000                                                                          
      cash paid for acquisitions, net of cash and restricted cash received
    		           231,000 0   0 0   0 0 -99,000 -476,392,000                                                                       
      cash paid for other intangibles
    		           0 -4,031,000   0 0   0 0 0 -1,400,000 -120,000 0 -1,030,000 -90,000 0 0                                                                 
      payments on loans payable
    		                                                                                             
      repurchase of common stock
    		       0 0 -250,000,000 -174,744,000 -174,876,000 0 -173,867,000 -228,024,000         0 0 -775,000 -17,930,000 -14,263,000 -31,859,000   -13,067,000 -6,768,000                                   0 -21,998,000   0    0 0          -2,485,000 -4,968,000 -31,035,000     
      payment of excise tax on share repurchases
    		                                                                                             
      earn-out payments to settle contingent consideration liabilities for prior acquisitions
    		       0        0 0                                                                             
      net decrease in cash, cash equivalents and restricted cash
    		        33,269,000 -28,048,000 -33,454,000                                                                                   
      cash, cash equivalents and restricted cash at beginning of year
    		                                                                                             
      cash, cash equivalents and restricted cash at end of year
    		                                                                                             
      acquisitions:
    		                                                                                             
      fair value of tangible assets acquired in acquisitions, net of cash and restricted cash received
    		           -127,000 0   0 -4,000   29,000 -164,000 -1,372,000 37,240,000  868,000                                                                     
      goodwill
    		           -311,000 0   -942,000 409,000   -5,456,000 -133,000 18,586,000 255,974,000 8,941,000 -1,846,000 123,447,000 26,494,000 207,000 -835,000                           411,000    -2,125,000        0 0 0 11,557,000 -488,000 0       104,885,000 1,000         0 -53,000   
      intangible assets
    		           0 0   0 0   0 0 -24,000,000 252,000,000 9,000,000 2,400,000 89,300,000 6,880,000 -1,000 1,000                           0    3,639,000        0 0 0 13,960,000 0 0                     
      liabilities assumed
    		           207,000 0   942,000 -405,000   5,427,000 297,000 6,885,000 -68,822,000 3,725,000 -1,349,000 -30,134,000 -3,390,000 -206,000 -302,000                                       166,000 -166,000 -3,000 -1,004,000 0 0       -57,504,000 0         0 73,000   
      contingent consideration liabilities
    		           0 0                                                                                 
      net cash paid for acquisitions
    		           -231,000 0   0 0   0 0 99,000 476,392,000 19,684,000 73,000 198,624,000 29,525,000 -1,000 -686,000                                       166,000 0   -4,000 0                 0 27,000   
      excise tax payable on share repurchases
    		       -38,000 219,000 1,964,000 1,556,000                                                                                   
      write-off of fees on credit facilities and senior notes
    		               0 0 0 158,000                                                                           
      restricted investments balance
    		               333,000 -3,000 -3,000 22,000 -3,000 6,000 -15,000 21,000 -21,000 6,000 57,000 36,000 -6,000 -93,000 19,000 -12,000                                                               
      purchase of equity investment
    		                0 0 -500,000                                                                           
      cash paid for initial direct costs
    		                                                                                             
      payments on term loans
    		               0 0 0 -21,875,000 -25,000,000 -201,562,000   -149,062,000        0 -18,125,000 -25,000,000 -938,000                                                           
      change in fair value of contingent consideration
    		           -1,740,000 -1,770,000       6,600,000 -6,700,000 4,800,000 200,000 4,895,000 4,441,000 -1,458,000 -700,000 -1,093,000 -1,326,000   118,000 20,000 23,000 23,000 64,000 -302,000 115,000 99,000 -30,000                                                      
      loss on disposal or sale of fixed assets
    		           989,000 92,000 238,000 241,000 2,321,000 3,000 30,000 353,000 658,000 343,000 55,000 3,266,000 35,000 410,000 35,000 4,000 77,000 1,000 34,000 5,000 97,000 87,000 -22,000 65,000 24,000 22,000   1,000    10,000 46,000 3,000 1,000 1,000 5,000 0 8,000 16,000 2,000 14,000 0 8,000 27,000 28,000 45,000 15,000 43,000 59,000 6,000 17,000 902,000 31,000 29,000 87,000 67,000 23,000 50,000  0 5,000 24,000         76,000 -2,000         
      purchase of convertible promissory notes
    		                   0                                                                          
      cash received for working capital adjustments for prior year acquisitions
    		                   0 0 0 66,000                                                                       
      proceeds from term loans
    		                    0 0 250,000,000  0                                                                     
      proceeds from senior notes
    		                   350,000,000                                                                          
      redemption of senior notes
    		                                                                                             
      net gain on investments
    		              174,000                                                                               
      net income on deferred compensation balances
    		               -76,000 -149,000   848,000 419,000                                                                         
      amortization of discount on investments
    		               -11,000 -6,000 -5,000 -30,000 -13,000 -25,000 -21,000 -50,000 -22,000 -47,000 -109,000 -120,000 -124,000 -16,000 -47,000 -15,000 -15,000 -70,000                                                             
      purchase of equity investments
    		                                                                                             
      proceeds from maturity of investments
    		                9,300,000 5,500,000 25,200,000 11,300,000 7,400,000 4,500,000 9,600,000 3,500,000 5,965,000 10,970,000 11,700,000 14,600,000 2,200,000 5,300,000 2,900,000 3,101,000 9,000,000 6,200,000 2,000,000                                                           
      earn-out payments for prior acquisitions
    		                  -3,100,000 0 0 0 -10,622,000 0 0   0 0 0 -1,713,000 0 0 0 -3,677,000                                                           
      proceeds from term loan
    		                                   0 0 0 75,000,000     0                                                  
      earn-out liabilities
    		                       -3,100,000 0 -10,622,000 -1,500,000 0 0                                                                 
      write-off of fees on credit facilities
    		                                                                                             
      purchase of convertible promissory note
    		                     0 -490,000                                                                       
      increase in allowances for doubtful accounts and sales credits
    		                       -534,000 1,831,000 2,370,000 2,608,000 2,766,000 1,431,000 2,552,000 2,257,000 1,327,000 1,272,000 2,332,000 5,408,000 5,262,000 1,294,000 2,765,000 2,687,000 1,369,000 1,240,000 1,883,000 2,192,000 1,478,000 762,000 1,710,000 443,000 1,949,000 1,031,000 546,000 1,102,000 1,484,000 1,849,000 1,447,000 2,006,000    1,084,000    439,000                               
      equity investment
    		                           -1,500,000    0 0                                                             
      cash paid for acquisitions, net of cash received
    		                       -19,684,000 -73,000 -198,624,000 -29,525,000 1,000 686,000       59,000 -203,000 -51,120,000 -165,230,000 -2,984,000                                                      
      cash paid for other liabilities, working capital adjustments and holdback liability for prior year acquisitions
    		                                                                                             
      proceeds from termination of derivative contract
    		                                0                                                             
      fair value of tangible assets acquired in acquisitions, net of cash received
    		                          1,041,000 -1,000 450,000                                                                 
      write-off of fees on the prior credit facilities
    		                           0 0                                                                 
      excess tax benefit from equity awards vested and exercised
    		                                                                                             
      capital lease repayments
    		                                   -1,000 -4,000   0 0 0 -4,000 -57,000 -159,000 -157,000 -156,000 -202,000 -161,000 -160,000 -158,000 -158,000 -162,000 -162,000 -168,000    -166,000     -339,000 -167,000   -176,000 -165,000 -163,000 -163,000 -159,000 -158,000 -157,000 -157,000 -177,000 -144,000 -118,000 -105,000 -103,000 -106,000 -73,000 -82,000 -99,000 -72,000 -81,000 -85,000 -69,000 -69,000 -73,000 -73,000 -68,000 -30,000 
      proceeds from termination (payment on reduction) of derivative contract
    		                                                                                             
      holdback provision
    		                                                                   0 0 0 -2,336,000                       
      cash paid for working capital adjustments and holdback liability for prior year acquisitions
    		                                   -500,000 -500,000                                                         
      loss on debt extinguishment
    		                              574,000             0 0   0    0 0                                         
      restricted cash, cash equivalents and investments balance
    		                               -30,260,000 -6,264,000 -8,448,000 4,951,000 7,088,000     -3,727,000 -1,926,000 -205,000 36,000 -3,081,000 -3,082,000 -2,875,000 -1,076,000 -1,075,000                                             
      change in restricted cash, cash equivalents and investments balance
    		                               1,314,000 606,000 -4,000 -1,000         1,409,000 2,675,000 4,117,000 4,349,000 0 -4,000 -9,000 60,000                                           
      proceeds from exercise of equity awards
    		                                       0 310,000 154,000 3,199,000 0 1,734,000 0 58,000 3,000 407,000 56,000 711,000          0   0 0   -6,000 584,000   -1,000 209,000                     
      net increase in cash and cash equivalents
    		                               -4,478,000 -3,253,000 -14,833,000 27,089,000  -5,354,000 -2,044,000 13,530,000  -66,000        21,134,000 8,580,000 -3,742,000  -11,675,000 10,597,000 939,000 -681,000 -3,281,000 3,990,000 2,051,000 -194,000 -39,291,000 4,801,000 9,514,000 4,432,000 -867,000 6,813,000 5,359,000 3,511,000 -551,000 521,000 -10,660,000 12,325,000 -11,357,000 7,306,000 5,799,000 911,000 -1,377,000 -5,432,000 -8,790,000 4,371,000 -99,000 4,320,000 6,610,000 -5,299,000 -4,624,000 -51,390,000 12,570,000 14,874,000 -11,502,000 -18,756,000 28,116,000 5,487,000 9,634,000 
      cash and cash equivalents at beginning of year
    		                                                  5,681,000                                           
      cash and cash equivalents at end of year
    		                                                  1,939,000                                           
      excess tax benefits from share-based compensation
    		                                    0 -442,000 -2,322,000  -458,000 -1,782,000 -5,029,000  -64,000 -170,000 -1,546,000  -98,000 -727,000 -704,000                                           
      excess tax benefits from equity awards vested and exercised
    		                                                                                             
      cash and cash equivalents at beginning of period
    		                                0 0 10,622,000  0 0 9,576,000   0 13,073,000    15,580,000  0    0 0 3,962,000  0 0 1,883,000  0 0 27,053,000  0 0 11,316,000  0 0 18,495,000  0 0 4,422,000  0 0 19,110,000  0 0 3,908,000  0  0 0 40,135,000  0 0 15,654,000 
      cash and cash equivalents at end of period
    		                                -3,253,000 -14,833,000 37,711,000       2,841,000 11,633,000    9,269,000  21,134,000    -11,675,000 10,597,000 4,901,000  -3,281,000 3,990,000 3,934,000  -39,291,000 4,801,000 36,567,000  -867,000 6,813,000 16,675,000  -551,000 521,000 7,835,000  -11,357,000 7,306,000 10,221,000  -1,377,000 -5,432,000 10,320,000  -99,000 4,320,000 10,518,000  -4,624,000  12,570,000 14,874,000 28,633,000  28,116,000 5,487,000 25,288,000 
      equity method investment
    		                                           0 -2,000,000 -1,000,000 -2,000,000                                               
      earn-out payment for prior acquisition
    		                                   0 0 0 -900,000                                                       
      payment on reduction of derivative contract
    		                                                                                             
      net change in cash and cash equivalents
    		                                                                                             
      liabilities and deferred revenue assumed
    		                                                                                             
      adjustments to reconcile net income to net cash from operating activities, net of acquisitions:
    		                                                                                             
      equity method investment in pipeline health holdings llc
    		                                                                                             
      payments on term loan
    		                                    -2,813,000 -2,812,000 -2,813,000 -1,875,000 -1,875,000 -1,875,000 -1,875,000 -1,875,000                                                  
      restricted cash and cash equivalents balance
    		                                     -1,314,000 176,000                                                       
      loan to pipeline health holdings llc
    		                                          -667,000                                                   
      cash paid for working capital adjustments for prior year acquisition
    		                                                                                             
      holdback settlement in equity from prior acquisition
    		                                               0 0                                             
      change in restricted cash and cash equivalents balance
    		                                                        -8,000   0 0 1,061,000 3,000                               
      proceeds from sales of assets held for sale
    		                                               0    406,000 22,000 272,000 8,350,000                                       
      prepaid expenses and other current assets
    		                                         -5,258,000 -3,063,000 2,171,000 -1,182,000 -48,000 -954,000 843,000 1,720,000 5,897,000 -2,436,000 -4,779,000 -618,000 1,746,000 -5,033,000 -445,000 898,000 1,447,000 -2,725,000 -429,000 966,000 5,387,000 -4,739,000 1,078,000 2,248,000 2,183,000 463,000 -83,000 1,242,000 -646,000 -3,092,000 1,038,000 397,000 676,000 -1,541,000 821,000 -1,095,000 3,322,000 -1,046,000 1,161,000 -384,000 1,416,000 -364,000 1,171,000 -253,000  1,988,000 1,230,000 -3,617,000     
      convertible loan to pipeline health holdings llc
    		                                                                                             
      cash paid for acquisition, net of cash received
    		                                         0 -76,945,000                          0    0    0    -1,000             
      cash paid for working capital adjustments for prior acquisition
    		                                         0 -165,000                                                   
      (gain) loss on disposal or sale of fixed assets
    		                                          -2,000                                     45,000 7,000 2,000 -63,000           
      net decrease in cash and cash equivalents
    		                                          -1,440,000    -6,311,000                                               
      excess tax benefit from share-based compensation
    		                                                                                             
      gain on sale of discontinued operations
    		                                                                                             
      changes in assets and liabilities, net of effects from acquisition and divestiture:
    		                                                                                             
      prepayment penalty associated with the prior credit facilities
    		                                                   0 0                                         
      changes in assets and liabilities:
    		                                                                                             
      change in bank overdraft
    		                                              -127,000 169,000 -75,000 -25,000 165,000  3,201,000 -895,000 -2,290,000   640,000 -913,000          -2,329,000    -1,737,000 772,000 -9,485,000  -6,754,000 327,000 7,119,000  0 0 -1,093,000    1,705,000 -341,000 2,206,000  389,000 304,000 1,426,000 
      repayments on prior term loan
    		                                                                                             
      payments on current term loan
    		                                                                                             
      proceeds from current term loan
    		                                                                                             
      proceeds from prior revolving credit facility
    		                                                                                             
      repayments on prior revolving credit facility
    		                                                                                             
      proceeds from current revolving credit facility
    		                                                                                             
      payments on current revolving credit facility
    		                                                                                             
      non-cash interest expense
    		                                               286,000 -60,000 815,000 295,000 575,000 801,000 393,000 1,152,000 958,000 967,000 926,000 936,000 918,000 770,000 767,000 785,000 2,738,000 773,000 705,000 367,000  427,000 362,000 420,000  417,000 334,000 485,000  665,000 952,000 1,030,000  232,000 400,000 255,000    93,000 109,000 109,000  86,000   
      impairment charges for discontinued operations
    		                                                                                             
      write-off of assets due to discontinued operations
    		                                                                                             
      cash payment for holdback liability for prior year acquisitions
    		                                                                                             
      cash paid for acquisitions
    		                                                                                             
      payments on term loan credit facility
    		                                               0 -5,000,000                                             
      proceeds from term loan credit facility, net of discount
    		                                                                                             
      repayments of prior notes payable
    		                                                   0 0                                         
      changes in assets and liabilities, net of effects from divestiture:
    		                                                                                             
      deposits and other assets
    		                                                 -1,448,000 -1,608,000 -816,000 -1,247,000 520,000 -1,377,000 -115,000 271,000 -251,000 -152,000 -406,000 -260,000 183,000 -428,000 -96,000 -991,000 -323,000 2,381,000 1,065,000 -2,950,000 -519,000 -284,000 -167,000 -602,000 -674,000 -1,082,000 -819,000 -841,000 4,779,000 -889,000 228,000 -970,000 -688,000 -33,000 -326,000 76,000         
      stock-based compensation
    		                                                  1,702,000 1,646,000 1,569,000 1,577,000 1,432,000 1,723,000 1,697,000 1,723,000 1,989,000 1,940,000 1,955,000 2,040,000 2,349,000 1,948,000 1,931,000 2,155,000 2,675,000 2,391,000 2,426,000 2,382,000 2,123,000    1,795,000                   
      payments on notes payable
    		                                                      -9,815,000 -4,625,000 -4,625,000 -2,312,000 -2,313,000 -2,312,000 -2,387,000 -1,375,000 -1,375,000 -77,270,000 -12,712,000 -23,050,000 -1,784,000 -6,645,000 -7,737,000 -3,769,000 -14,001,000 -10,140,000 -10,152,000 -2,691,000 -3,860,000 -27,260,000 -10,585,000   -93,325,000 -1,089,000 -1,088,000 -11,716,000 -3,493,000 -23,284,000         
      excess tax benefit from stock options and sars exercised and rsus vested
    		                                                                   7,000 -18,000   18,000 -29,000                     
      impairment charges for continuing operations
    		                                                                                             
      payment of prior notes payable discount
    		                                                                                             
      payments on new term loan credit facility
    		                                                   -12,000,000 -24,000,000                                         
      proceeds from new term loan credit facility, net of discount
    		                                                   0 0                                         
      proceeds from prior notes payable
    		                                                                                             
      net settlement of employee equity awards
    		                                                        -41,000 -1,271,000 -734,000  -34,000                                 
      payment on nf investors, inc. (“nfi”) then-existing debt
    		                                                                                             
      excess tax benefits from sars exercised and rsus vested and issued
    		                                                                                             
      impairment charges
    		                                                           1,050,000 49,782,000   0 0 0 175,707,000                           
      gain on sale of discontinued operations, net of tax
    		                                                    0 0 -1,187,000                                       
      change in restricted cash and cash equivalents and investments balance
    		                                                    -582,000 -94,000 3,000                                       
      payments of employee tax withholdings from equity transactions
    		                                                    -29,000 -187,000 -656,000         0                              
      excess tax benefit from sars exercised and rsus vested and issued
    		                                                            0                                 
      excess tax benefits from rsus vested and issued
    		                                                                                             
      excess tax benefit from rsus vested and issued
    		                                                     17,000 -6,000                                       
      changes in assets and liabilities, net of effects from divesture:
    		                                                                                             
      payment of notes payable discount
    		                                                       0    0                                  
      proceeds from notes payable
    		                                                       0    0                                  
      payments on termination of derivative contracts
    		                                                                                             
      change in bank overdraft, net of overdraft acquired
    		                                                       -1,264,000    422,000    0 -3,274,000 3,274,000 -3,995,000    6,598,000                       
      cash (received) paid for income taxes
    		                                                                                             
      supplemental disclosures of noncash investing and financing activities:
    		                                                                                             
      fixed assets acquired through capital leases
    		                                                            0   0 0 163,000 1,982,000 179,000 0 38,000 26,000 118,000 17,000 137,000 46,000 0 43,000 679,000 71,000 0 -15,000   0          
      fair value of assets acquired in acquisitions, net of cash received
    		                                                                      8,778,000                   -8,000 7,000   
      nfi then-existing debt
    		                                                                                             
      preferred stock issued
    		                                                       0    263,000                                  
      common stock issued
    		                                                       0    0                                  
      increase in allowance for doubtful accounts and sales credits
    		                                                        935,000    1,856,000                                 
      excess tax benefit from sars exercised and rsus vested
    		                                                        -202,000                                     
      changes in assets and liabilities, net of effects from acquisition:
    		                                                                                             
      other liabilities and deferred revenue
    		                                                        -907,000                                     
      cash payment for holdback liability for prior acquisitions
    		                                                                                             
      capital lease payments
    		                                                        -169,000    -162,000 -159,000 -161,000    -175,000                           
      payment of revolving credit facility
    		                                                                                             
      payments on nf investors, inc. (“nfi”) then-existing debt
    		                                                                                             
      cash paid for interest, including financing costs
    		                                                                                             
      fair value of assets acquired in acquisition, net of cash received
    		                                                                        0        0             
      nfi then-existing debt assumed
    		                                                                                             
      other liabilities assumed
    		                                                                                             
      net cash paid for acquisition
    		                                                                      30,789,000          1,000             
      excess tax benefits from sars exercised and rsus vested
    		                                                                                             
      excess tax benefits from stock options and sars exercised and rsus vested
    		                                                          -1,000                                   
      income taxes payable
    		                                                                   1,272,000 0 -3,162,000 237,000 -1,317,000 -2,452,000 7,808,000 3,522,000 14,533,000 444,000   -11,175,000 607,000 -633,000 734,000   -4,424,000 3,482,000 -3,479,000 4,865,000 -7,093,000    
      purchase of intangible assets
    		                                                                   0 0                         
      payment on nfi then-existing debt
    		                                                                                             
      deferred tax liability
    		                                                                       484,000 0                     
      excess tax benefit from stock options and stock appreciation rights (“sars”) exercised and rsus vested
    		                                                                                             
      income tax receivable
    		                                                                                             
      excess tax benefit from stock options and sars exercised and rsus vested and issued
    		                                                                                             
      fair value of tangible assets acquired in acquisition, net of cash received
    		                                                                                             
      adjustments to reconcile net income to net cash from operating activities, net of effects from acquisitions:
    		                                                                                             
      cash payment for holdback liability for 2005 acquisition
    		                                                                   0 0                         
      payment of employee tax withholdings from equity transactions
    		                                                                                             
      excess of net working capital payable
    		                                                                                             
      cash paid for acquisition
    		                                                                      -30,789,000                       
      excess net working capital payable
    		                                                                      -166,000                       
      noncash interest expense
    		                                                                                   248,000 711,000         
      payment on termination of derivative contract
    		                                                                                             
      change in bank overdraft, net of effects of acquisition
    		                                                                                             
      issuance of treasury stock for acquisition earn-out
    		                                                                                             
      benefit from bad debts
    		                                                                    980,000 1,167,000 1,435,000 1,567,000 1,034,000 502,000 588,000 687,000 759,000 1,019,000 344,000       -356,000 18,000 -6,000 29,000 23,000 849,000   
      excess tax benefit from stock options exercised
    		                                                                                             
      proceeds from stock options exercised
    		                                                                                             
      net change in foreign currency translation adjustment and unrealized loss on derivative financial instruments, net of tax
    		                                                                      -749,000                       
      adjustments to reconcile net income to net cash from operating activities, net of effects from acquisition:
    		                                                                                             
      proceeds from issuance of notes payable
    		                                                                           1,600,000 0      2,500,000           
      net change in foreign currency translation adjustment and unrealized gain on derivative financial instruments, net of tax
    		                                                                       -521,000 -555,000 292,000 -265,000 177,000 -1,654,000 736,000 1,137,000 -570,000 79,000 -196,000 162,000 247,000 -235,000         
      earn-out liability
    		                                                                                             
      treasury stock issued
    		                                                                                             
      non-cash stock-based compensation
    		                                                                        2,266,000   1,788,000 1,857,000 1,791,000 1,367,000 21,000 40,000 41,000 40,000 95,000 218,000 219,000 218,000 219,000 218,000  219,000   
      cash paid (received) for income taxes
    		                                                                                             
      issuance of treasury stock for acquisition earnout
    		                                                                           0 -7,000 0 10,667,000               
      excess tax benefit from stock option exercises
    		                                                                          -3,132,000 -15,807,000 4,415,000 1,677,000 483,000               
      cash paid for acquisition earnout
    		                                                                              -35,963,000               
      proceeds from issuance of common stock
    		                                                                          1,066,000    3,206,000  160,000 988,000 828,000  538,000         
      proceeds from exercise of stock options
    		                                                                           8,810,000 10,272,000                 
      gain on disposal or sale of fixed assets
    		                                                                            45,000                 
      issuance costs of common stock
    		                                                                                0             
      benefit from (recovery of) bad debts
    		                                                                               835,000 241,000 460,000 202,000           
      stock-based compensation in connection with tender offer
    		                                                                                             
      cash paid under deferred purchase agreement
    		                                                                                     0 0       
      repurchase of common stock and options, including transaction costs
    		                                                                                             
      proceeds from issuance of common stock, net of issuance costs
    		                                                                                     -1,000    -1,080,000 994,000   
      accrued earn-out
    		                                                                                             
      repurchase of common stock and options
    		                                                                                             
      noncompete covenants
    		                                                                                0         8,000 0   
      proceeds from sale of short-term investments
    		                                                                                             
      (recovery of) benefit from bad debts
    		                                                                                    307,000         
      purchase of fixed assets
    		                                                                                    -1,458,000 -1,955,000 -4,026,000 -3,772,000 -3,260,000 -1,030,000 -1,166,000 -1,184,000 -948,000 
      cost of repurchase of common stock into treasury
    		                                                                                    0         
      effect of exchange rate changes on cash and cash equivalents
    		                                                                                    -19,000         
      fixed assets obtained through capital leases
    		                                                                                      126,000 72,000 8,000  40,000 1,196,000 26,000 
      loss on extinguishment of debt
    		                                                                                             
      income taxes receivable and other current assets
    		                                                                                         -279,000 -4,619,000   
      deposits
    		                                                                                     -47,000 -14,000 -77,000 -85,000 -64,000 -76,000   
      due to former shareholder
    		                                                                                             
      purchase of short-term investments
    		                                                                                             
      change in bank overdraft, net of effects of acquisitions
    		                                                                                             
      accrued interest on notes payable converted to notes payable
    		                                                                                             
      earnout provision accrual
    		                                                                                             
      deferred income tax benefit
    		                                                                                      0 1,600,000 750,000     
      gain on disposal of fixed assets
    		                                                                                             
      changes in assets and liabilities, net of effects from acquisitions in 2002:
    		                                                                                             
      proceeds from maturity of short-term held-to-maturity investments
    		                                                                                          -1,522,000   
      acquisitions, net of cash acquired
    		                                                                                          -27,000   
      offering costs
    		                                                                                             
      effect of exchange rates changes on cash
    		                                                                                      -10,000       
      non-compete covenants
    		                                                                                             
      extraordinary loss on extinguishment of debt
    		                                                                                             
      present value of deferred purchase payments
    		                                                                                             
      loss on disposal of fixed assets
    		                                                                                             
      cash paid for deferred purchase agreement
    		                                                                                             
      accrued interest on notes payable converted to additional notes payable
    		                                                                                             
      deferred income taxes
    		                                                                                             
      adjustments to reconcile net income to net cash provided by operating activities:
    		                                                                                             
      proceeds from maturity of short-term held-to-maturity investments
    		                                                                                            4,148,000 
      costs of issuance of common stock
    		                                                                                            -63,000 
      supplemental disclosures of non-cash investing and financing activities:
    		                                                                                             
      accrued interest on notes payable converted to additional notes payable
    		                                                                                             
      purchase of short-term held-to-maturity investments
    		                                                                                             
      acquisitions, including acquisition costs
    		                                                                                             
      proceeds from issuance of common stock, net of issuance costs
    		                                                                                             
      change in bank overdraft, net of effects of acquisitions
    		                                                                                             
      net increase in cash and cash equivalents
    		                                                                                             
      supplemental disclosures of noncash investing and financing activities:
    		                                                                                             
      common stock issued in exchange for minority interest
    		                                                                                             
      accrued interest on notes payable converted to notes payable
    		                                                                                             
      fair value of assets acquired in acquisitions, net of cash received
    		                                                                                             
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.